Plasma membrane ion permeability induced by mutant α‐synuclein contributes to the degeneration of neural cells
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Mutations in α‐synuclein cause some cases of familial Parkinson's disease (PD), but the mechanism by which α‐synuclein promotes degeneration of dopamine‐producing neurons is unknown. We report that human neural cells expressing mutant α‐synuclein (A30P and A53T) have higher plasma membrane ion permeability. The higher ion permeability caused by mutant α‐synuclein would be because of relatively large pores through which most cations can pass non‐selectively. Both the basal level of [Ca 2+]i and the Ca 2+ response to membrane depolarization are greater in cells expressing mutant α‐synuclein. The membrane permeable Ca 2+ chelator BAPTA‐AM significantly protected the cells against oxidative stress, whereas neither l‐type (nifedipine) nor N‐type (ω‐conotoxin‐GVIA) Ca 2+ channel blockers protected the cells. These findings suggest that the high membrane ion permeability caused by mutant α‐synuclein may contribute to the degeneration of neurons in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · cited 1×
“…of a-synuclein (A30P and A53T) have been discovered in autosomal dominant familial Parkinson’s disease (PD) cases (Polymeropoulos et al. 1997; Kruger et al. 1998), and a-synuclein is a primary constituent of Lewy bodies and Lewy neurites, which are neuropathological hallmarks of PD…”
BackgroundKinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Choo, Y. S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh162 · Cited by 515
Furukawa, K., Smith-Swintosky, V. L., & Mattson, M. P. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1018 · Cited by 81
Self-citation
Cited by
Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding
Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Hengerer, B., & Kostka, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2617-07.2007 · Cited by 765
Mattson, M. P. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00275.x · Cited by 751
“PD α-synuclein mutations have been shown to perturb Ca2+ homeostasis in cultured neurons by increasing membrane ion permeability (Volles & Lansbury, 2002; Furukawa et al., 2006).”
BackgroundInfluentialNeuronal calcium signaling: function and dysfunction
Brini, M., Calì, T., Ottolini, D., & Carafoli, E. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1550-7 · Cited by 748
Calcium signaling and neurodegenerative diseases
Bezprozvanny, I. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.001 · Cited by 469
α-Synuclein and neuronal cell death
Cookson, M. R. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-9 · Cited by 418
Metadata
- Authors
- Furukawa, K., Matsuzaki‐Kobayashi, M., Hasegawa, T., Kikuchi, A., Sugeno, N., Itoyama, Y., Wang, Y., Yao, P. J., Bushlin, I., & Takeda, A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-04-05
- Volume
- 97
- Issue
- 4
- Pages
- 1071-1077
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2083243127
- Cited by
- 113
- References
- 5
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.